Back

prof. dr. G.D. Valk

prof. dr. G.D. Valk

Full Professor

Show full profile

Research Output (215)

Update on the clinical management of multiple endocrine neoplasia type 1

Pieterman Carolina R.C., Valk Gerlof D. Oct 2022, In: Clinical Endocrinology. 97 , p. 409-423 15 p.

NETest:serial liquid biopsies in gastroenteropancreatic NET surveillance

van Treijen Mark J.C., Korse Catharina M., Verbeek Wieke H., Tesselaar Margot E.T., Valk Gerlof D. Oct 2022, In: Endocrine connections. 11 12 p.

Four decades of experience with carcinoid heart disease:An analysis of 84 patients

Levy Sonja, Korse Catherina E, de Groot Andre C A, Meijer Ronald C A, Tesselaar Margot E T, Valk Gerlof D 9 Sep 2022, In: Journal of Neuroendocrinology. 34 9 p.

Correction: Lebbink et al. Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span. Cancers 2021, 13, 5104.:Lebbink et al. Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span. (Cancers 2021, 13, 5104)

Lebbink Chantal A, van den Broek Medard F M, Kwast Annemiek B G, Derikx Joep P M, Dierselhuis Miranda P, Kruijff Schelto, Links Thera P, van Trotsenburg A S Paul, Valk Gerlof D, Vriens Menno R, Verrijn Stuart Annemarie A, van Santen Hanneke M, Karim-Kos Henrike E 14 Jun 2022, In: Cancers. 14

Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study

Levy Sonja, Kilgallen Aoife B, Korse Catharina M, Oerlemans Marish I F J, Sluijter Joost P G, van Laake Linda W, Valk Gerlof D, Tesselaar Margot E T 1 May 2022, In: Cancers. 14 , p. 1-13

FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels

Lebbink Chantal A., de Vries Lisa H., Borel Rinkes Inne H.M., Braat Arthur J.A.T., van Leeuwaarde Rachel S., Lodewijk Lutske, van Treijen Mark J.C., Vriens Menno R., Valk Gerlof D., van Santen Hanneke M., de Keizer Bart 1 Apr 2022, In: European Journal of Endocrinology. 187 , p. 101-110 10 p.

Risk factors for complications after surgery for pancreatic neuroendocrine tumors

van Beek Dirk-Jan, Takkenkamp Tim J., Wong-Lun-Hing Edgar M., Kleine Ruben H. J. de, Walenkamp Annemiek M. E., Klaase Joost M., Nijkamp Maarten W., Valk Gerlof D., Molenaar I. Quintus, Hagendoorn Jeroen, Santvoort Hjalmar C. van, Rinkes Inne H. M. Borel, Hoogwater Frederik J. H., Vriens Menno R. 24 Mar 2022, In: Surgery. 172 , p. 127-136 10 p.

Defining disease status in gastroenteropancreatic neuroendocrine tumors:Choi-criteria or RECIST?

van Treijen M J C, Schoevers J M H, Heeres B C, van der Zee D, Maas M, Valk G D, Tesselaar M E T Mar 2022, In: Abdominal Radiology. 47 , p. 1071-1081 11 p.

Is There a Role for Biomarkers in Surveillance of Pancreatic Neuroendocrine Neoplasms in Von Hippel-Lindau Disease?

Naber Myrthe R, Ahmad Saya, Verrijn Stuart Annemarie A, Giles Rachel H, Valk Gerlof D, van Leeuwaarde Rachel S 1 Feb 2022, In: JOURNAL OF THE ENDOCRINE SOCIETY. 6 , p. 1-6

A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility

Modlin I. M., Kidd M., Falconi M., Filosso P. L., Frilling A., Malczewska A., Toumpanakis C., Valk G., Pacak K., Bodei L., Öberg K. E. Nov 2021, In: Annals of Oncology. 32 , p. 1425-1433 9 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not